Professor of Microbial Pathogenesis
Head of UPCOL, a world-class research unit dedicated to TB drug discovery, unraveling the pathogenesis of tuberculosis and studying the phylogeography of leprosy.
Director of the Global Health Institute
Professor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.
In addition to EPFL core funding, UPCOL gratefully acknowledges the financial support of the Fondation Raoul Follereau, the European Commission (LHSP-CT-2005-018923), the Bill and Melinda Gates Foundation, and the National Institutes of Health (NIAID RO1-AI47197-01A1).
Enseignement & Phd
- Doctoral Program in Biotechnology and Bioengineering
- Doctoral Program in Molecular Life Sciences